Wista Pharmaceutical
Nanjing, China· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
Overview
A pharma company developing novel small molecule drugs for cardiovascular and metabolic disorders.
CardiovascularMetabolic
Technology Platform
Leverages integrated medicinal chemistry and translational biology platforms to design and optimize novel small molecule drug candidates.
Opportunities
Addressing large patient populations with significant unmet needs, particularly for safer or more convenient therapies.
Risk Factors
High clinical development risk and difficulty in demonstrating superiority over established, often generic, standard-of-care treatments.
Competitive Landscape
Competes in mature therapeutic areas dominated by large, entrenched pharmaceutical companies with vast resources.